Logo image of NRC

NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis

NASDAQ:NRC - Nasdaq - US6373722023 - Common Stock - Currency: USD

17.96  -0.09 (-0.5%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to NRC. NRC was compared to 108 industry peers in the Health Care Providers & Services industry. While NRC has a great profitability rating, there are some minor concerns on its financial health. NRC has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year NRC was profitable.
In the past year NRC had a positive cash flow from operations.
In the past 5 years NRC has always been profitable.
In the past 5 years NRC always reported a positive cash flow from operatings.
NRC Yearly Net Income VS EBIT VS OCF VS FCFNRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

1.2 Ratios

The Return On Assets of NRC (20.54%) is better than 100.00% of its industry peers.
The Return On Equity of NRC (78.20%) is better than 96.26% of its industry peers.
With an excellent Return On Invested Capital value of 30.89%, NRC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
NRC had an Average Return On Invested Capital over the past 3 years of 38.44%. This is significantly above the industry average of 8.27%.
The 3 year average ROIC (38.44%) for NRC is well above the current ROIC(30.89%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 20.54%
ROE 78.2%
ROIC 30.89%
ROA(3y)24.47%
ROA(5y)26.09%
ROE(3y)50.42%
ROE(5y)61.46%
ROIC(3y)38.44%
ROIC(5y)38.36%
NRC Yearly ROA, ROE, ROICNRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 50 100 150

1.3 Margins

The Profit Margin of NRC (18.78%) is better than 100.00% of its industry peers.
NRC's Profit Margin has declined in the last couple of years.
NRC has a better Operating Margin (26.12%) than 100.00% of its industry peers.
NRC's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 60.89%, NRC belongs to the best of the industry, outperforming 84.11% of the companies in the same industry.
In the last couple of years the Gross Margin of NRC has remained more or less at the same level.
Industry RankSector Rank
OM 26.12%
PM (TTM) 18.78%
GM 60.89%
OM growth 3Y-5.19%
OM growth 5Y-1.76%
PM growth 3Y-9.28%
PM growth 5Y-3.56%
GM growth 3Y-0.42%
GM growth 5Y0.68%
NRC Yearly Profit, Operating, Gross MarginsNRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

NRC has less shares outstanding than it did 1 year ago.
NRC has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, NRC has a worse debt to assets ratio.
NRC Yearly Shares OutstandingNRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
NRC Yearly Total Debt VS Total AssetsNRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

NRC has an Altman-Z score of 4.35. This indicates that NRC is financially healthy and has little risk of bankruptcy at the moment.
NRC's Altman-Z score of 4.35 is amongst the best of the industry. NRC outperforms 81.31% of its industry peers.
The Debt to FCF ratio of NRC is 2.13, which is a good value as it means it would take NRC, 2.13 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.13, NRC belongs to the best of the industry, outperforming 82.24% of the companies in the same industry.
NRC has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.44, NRC is not doing good in the industry: 71.96% of the companies in the same industry are doing better.
Even though the debt/equity ratio score it not favorable for NRC, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 2.13
Altman-Z 4.35
ROIC/WACCN/A
WACCN/A
NRC Yearly LT Debt VS Equity VS FCFNRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.47 indicates that NRC may have some problems paying its short term obligations.
NRC has a Current ratio of 0.47. This is amonst the worse of the industry: NRC underperforms 91.59% of its industry peers.
A Quick Ratio of 0.47 indicates that NRC may have some problems paying its short term obligations.
With a Quick ratio value of 0.47, NRC is not doing good in the industry: 90.65% of the companies in the same industry are doing better.
NRC does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47
NRC Yearly Current Assets VS Current LiabilitesNRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for NRC have decreased by -3.12% in the last year.
NRC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.24% yearly.
Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -3.07% in the last year.
NRC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.42% yearly.
EPS 1Y (TTM)-3.12%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-25.14%
Revenue 1Y (TTM)-3.07%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-5.62%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRC Yearly Revenue VS EstimatesNRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
NRC Yearly EPS VS EstimatesNRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.2 0.4 0.6 0.8 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.37, which indicates a correct valuation of NRC.
83.18% of the companies in the same industry are more expensive than NRC, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 28.58, NRC is valued a bit cheaper.
Industry RankSector Rank
PE 14.37
Fwd PE N/A
NRC Price Earnings VS Forward Price EarningsNRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

71.03% of the companies in the same industry are more expensive than NRC, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, NRC is valued a bit cheaper than 76.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.6
EV/EBITDA 11.25
NRC Per share dataNRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The excellent profitability rating of NRC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.43
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

NRC has a Yearly Dividend Yield of 2.78%.
NRC's Dividend Yield is rather good when compared to the industry average which is at 2.86. NRC pays more dividend than 94.39% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, NRC pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

On average, the dividend of NRC grows each year by 16.85%, which is quite nice.
NRC has been paying a dividend for at least 10 years, so it has a reliable track record.
NRC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)16.85%
Div Incr Years3
Div Non Decr Years3
NRC Yearly Dividends per shareNRC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1

5.3 Sustainability

NRC pays out 42.78% of its income as dividend. This is a bit on the high side, but may be sustainable.
NRC's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP42.78%
EPS Next 2YN/A
EPS Next 3YN/A
NRC Yearly Income VS Free CF VS DividendNRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
NRC Dividend Payout.NRC Dividend Payout, showing the Payout Ratio.NRC Dividend Payout.PayoutRetained Earnings

More info and screens

NATIONAL RESEARCH CORP

NASDAQ:NRC (1/24/2025, 4:30:01 PM)

17.96

-0.09 (-0.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change0.34%
Ins OwnersN/A
Ins Owner Change0%
Market Cap0
Analysts45
Price TargetN/A
Short Float %N/A
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend1.49
Dividend Growth(5Y)16.85%
DP42.78%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.37
Fwd PE N/A
P/S 3.07
P/FCF 17.6
P/OCF 11.09
P/B 12.8
P/tB N/A
EV/EBITDA 11.25
EPS(TTM)1.25
EY6.96%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.02
FCFY5.68%
OCF(TTM)1.62
OCFY9.02%
SpS5.84
BVpS1.4
TBVpS-1.39
PEG (NY)N/A
PEG (5Y)4.43
Profitability
Industry RankSector Rank
ROA 20.54%
ROE 78.2%
ROCE 43.03%
ROIC 30.89%
ROICexc 32.09%
ROICexgc 141.93%
OM 26.12%
PM (TTM) 18.78%
GM 60.89%
FCFM 17.46%
ROA(3y)24.47%
ROA(5y)26.09%
ROE(3y)50.42%
ROE(5y)61.46%
ROIC(3y)38.44%
ROIC(5y)38.36%
ROICexc(3y)54.35%
ROICexc(5y)53.24%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)50.64%
ROCE(5y)50.54%
ROICexcg growth 3Y-21.81%
ROICexcg growth 5YN/A
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-7.33%
OM growth 3Y-5.19%
OM growth 5Y-1.76%
PM growth 3Y-9.28%
PM growth 5Y-3.56%
GM growth 3Y-0.42%
GM growth 5Y0.68%
F-Score4
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 2.13
Debt/EBITDA 1.14
Cap/Depr 248.91%
Cap/Sales 10.25%
Interest Coverage 19.8
Cash Conversion 91.64%
Profit Quality 92.99%
Current Ratio 0.47
Quick Ratio 0.47
Altman-Z 4.35
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)180.12%
Cap/Depr(5y)135.49%
Cap/Sales(3y)6.94%
Cap/Sales(5y)5.49%
Profit Quality(3y)88.14%
Profit Quality(5y)95.04%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.12%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-25.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.07%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-5.62%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.07%
EBIT growth 3Y-1.7%
EBIT growth 5Y2.58%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.86%
FCF growth 3Y-15.23%
FCF growth 5Y-8%
OCF growth 1Y-0.7%
OCF growth 3Y-2.12%
OCF growth 5Y-0.89%